Topical Estradiol for Cosmetic Anti-Aging

Introduction to Topical Estradiol

Topical estradiol is not recommended solely for cosmetic anti-aging purposes due to potential safety concerns and limited high-quality evidence supporting its use, as stated by the Hepatology journal 1

The U.S. Preventive Services Task Force (USPSTF) concludes there is zero to negative net benefit for combined estrogen and progestin therapy for prevention of chronic conditions 2
Even estrogen-only therapy is associated with important harms, including increased risk of stroke, deep vein thrombosis (DVT), and gallbladder disease 3

Absolute contraindications for topical estradiol include history of or current deep vein thrombosis or pulmonary embolism, ischemic heart disease, history of breast cancer, active viral hepatitis, severe liver disease, and migraine with aura at any age, as recommended by the Journal of the American Academy of Dermatology 4
Relative contraindications for topical estradiol include age ≥35 years and smoking, hypertension, diabetes with end-organ damage, and known hyperlipidemia, as recommended by the Journal of the American Academy of Dermatology 4

The FDA has not approved topical estradiol specifically for cosmetic anti-aging purposes, as stated by the Hepatology journal 1

For patients with a history of estrogen-related malignancies, caution is warranted when using topical estradiol for skin aging, as recommended by the American Society of Clinical Oncology 5
The safety profile of vaginal estrogen preparations, which are considered to have minimal systemic absorption for urogenital applications, may differ from that of facial application, according to the American College of Obstetricians and Gynecologists 6

Topical estrogen should not be recommended solely for cosmetic purposes in patients with contraindications to estrogen therapy, such as those with a history of hormone-sensitive cancers, as advised by the American Society of Clinical Oncology 5
Alternative approaches for skin aging, such as retinoids, sunscreen, and other evidence-based cosmeceuticals, may be preferable for patients with estrogen-related contraindications, as suggested by the American Academy of Dermatology 7

The American College of Oncology suggests that patients with a history of breast cancer should avoid topical estrogen due to potential risks, as evidenced by the role of topical vaginal estrogen in genitourinary symptoms with acceptable systemic absorption profiles 8, 9